- Investing Ideas
- Indian Pharmaceuticals & Biotech High ROE Growth Engines
Indian Pharmaceuticals & Biotech High ROE Growth Engines
Results
9
9 companies
Abbott India
Market Cap: ₹565.0b
Operates as a pharmaceutical company in India.
500488
₹26,587.05
7D
-5.1%
1Y
-19.6%
GlaxoSmithKline Pharmaceuticals
Market Cap: ₹488.4b
Manufactures, distributes, and trades in pharmaceuticals in India and internationally.
500660
₹2,883.20
7D
11.0%
1Y
2.3%
Ajanta Pharma
Market Cap: ₹463.1b
A pharmaceutical formulation company engages in the development, manufacture, and marketing of specialty pharmaceutical finished dosages.
AJANTPHARM
₹3,706.40
7D
5.7%
1Y
37.1%
Neuland Laboratories
Market Cap: ₹299.2b
Engages in the manufacture and sale of active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally.
524558
₹23,319.85
7D
1.6%
1Y
78.8%
CORONA Remedies
Market Cap: ₹129.6b
A pharmaceutical formulation company, develops, manufactures, and markets pharmaceutical products.
CORONA
₹2,119.40
7D
0.8%
1Y
n/a
Shukra Pharmaceuticals
Market Cap: ₹18.3b
Manufactures and markets pharmaceutical products in India and internationally.
524632
₹41.69
7D
11.9%
1Y
110.8%
Sat Kartar Life
Market Cap: ₹1.9b
An ayurvedic healthcare company, provides ayurvedic products in India.
SATKARTAR
₹121.05
7D
0.9%
1Y
-30.2%
Aanjaay Industries
Market Cap: ₹540.3m
Does not have significant operations.
524322
₹22.79
7D
-3.8%
1Y
15.6%
Colinz Laboratories
Market Cap: ₹201.5m
Manufactures, markets, and trades in pharmaceutical formulations in India.
531210
₹80.00
7D
0.4%
1Y
89.5%